4-环己基氨基哌啶-4-羧胺 | 83877-87-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-环己基氨基哌啶-4-羧胺
• 英文名称: 4-(Cyclohexylamino)piperidine-4-carboxamide
• CAS: 83877-87-6
• 化学式: C₁₂H₂₃N₃O
• 分子量: 225.33
• InChiKey: IUPNXQPHGAGYNA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  67.2
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090

文献信息

• [EN] 4-SUBSTITUTED PIPERIDINE DERIVATIVES<br/>[FR] DERIVES DE PIPERIDINE SUBSTITUES EN POSITION 4
  申请人：BIOAXONE THERAPEUTIQUE INC

  公开号：WO2005080394A1

  公开（公告）日：2005-09-01

  Substituted piperidine compounds represented by the structure I are provided, wherein each of Rla, R1b, R1c, R1d, Rle, R1f, R1g, R1h, R2, R2A, R3, R4, A, X, a, x, and n is as defined in the specification. Substituted piperidine compounds of structure I may permeate or penetrate across a nerve cell membrane into the interior of a nerve cell, may inhibit intracellular Rho kinase enzyme found in nerve cells in mammals, and may find utility in repair of damaged nerves in the central and peripheral nervous system of such mammals. These compounds may induce the regeneration or growth of neurites in mammalian nerve cells and may thereby induce regeneration of damaged or diseased nerve tissue. These compounds also find additional utility as antagonists of the enzyme Rho kinase in treatment of disease states in which Rho kinase is implicated. Pharmaceutical compositions containing these substituted piperidine compounds may be useful to promote neurite growth and in the treatment of diseases in which Rho kinase inhibition is indicated.

  提供了由结构I表示的取代哌啶化合物，其中Rla、R1b、R1c、R1d、Rle、R1f、R1g、R1h、R2、R2A、R3、R4、A、X、a、x和n中的每一个如规范中定义。结构I的取代哌啶化合物可能渗透或穿过神经细胞膜进入神经细胞内部，可能抑制哺乳动物神经细胞中的细胞内Rho激酶酶，并可能在这些哺乳动物的中枢和外周神经系统中修复受损神经时发挥作用。这些化合物可能诱导哺乳动物神经细胞中神经突起的再生或生长，从而诱导受损或患病神经组织的再生。这些化合物还可作为Rho激酶酶拮抗剂在治疗涉及Rho激酶的疾病状态中发挥额外作用。含有这些取代哌啶化合物的药物组合物可能有助于促进神经突起的生长，并在需要Rho激酶抑制的疾病治疗中发挥作用。
• 4-Substituted piperidine derivatives
  申请人：McKerracher Lisa

  公开号：US20050272751A1

  公开（公告）日：2005-12-08

  Substituted piperidine compounds represented by the structure I are provided, wherein each of R 1a , R 1b , R 1c , R 1d , R 1e , R 1f , R 1g , R 1h , R 2 , R 2A , R 3 , R 4 , A, X, a, x and n is as defined in the specification. Substituted piperidine compounds of structure I may permeate or penetrate across a nerve cell membrane into the interior of a nerve cell, may inhibit intracellular Rho kinase enzyme found in nerve cells in mammals, and may find utility in repair of damaged nerves in the central and peripheral nervous system of such mammals. These compounds may induce the regeneration or growth of neurites in mammalian nerve cells and may thereby induce regeneration of damaged or diseased nerve tissue. These compounds also find additional utility as antagonists of the enzyme Rho kinase in treatment of disease states in which Rho kinase is implicated. Pharmaceutical compositions containing these substituted piperidine compounds may be useful to promote neurite growth and in the treatment of diseases in which Rho kinase inhibition is indicated.

  提供了由结构式I表示的取代哌啶化合物，其中R1a、R1b、R1c、R1d、R1e、R1f、R1g、R1h、R2、R2A、R3、R4、A、X、a、x和n的定义如规范中所述。结构式I的取代哌啶化合物可以渗透或穿过神经细胞膜进入神经细胞内部，可以抑制哺乳动物神经细胞中发现的细胞内Rho激酶酶，并可用于修复哺乳动物中心和周围神经系统中的受损神经。这些化合物可以诱导哺乳动物神经细胞的轴突再生或生长，从而诱导受损或患病的神经组织再生。这些化合物还可作为Rho激酶酶拮抗剂，在治疗涉及Rho激酶酶的疾病状态中发现其他用途。含有这些取代哌啶化合物的制药组合物可用于促进神经轴突生长，并用于治疗需要Rho激酶抑制的疾病。
• SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION
  申请人：Bristol-Myers Squibb Pharma Company

  公开号：EP1268454A1

  公开（公告）日：2003-01-02
• PURINE COMPOUNDS AND USE THEREOF AS CANNABINOID RECEPTOR LIGANDS
  申请人：Pfizer Products Inc.

  公开号：EP1558615B1

  公开（公告）日：2007-08-29
• 4-SUBSTITUTED PIPERIDINE DERIVATIVES
  申请人：Bioaxone Therapeutique Inc.

  公开号：EP1720874A1

  公开（公告）日：2006-11-15